U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
- --------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
The Aries Master Fund, a Cayman Islands exempted company
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
787 Seventh Avenue, 48th Floor
- --------------------------------------------------------------------------------
(Street)
New York, NY 10019
- --------------------------------------------------------------------------------
(City) (State) (Zip)
- --------------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year)
1/25/2000
- --------------------------------------------------------------------------------
3. IRS Identification Number of Reporting Person, if an entity (Voluntary)
- --------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
Urogen Corp. (UROG)
- --------------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer
(Check all applicable)
|_| Director |X| 10% Owner
|_| Officer (give title below) |_| Other (specify below)
________________________________________
- --------------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
- --------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check applicable line)
|_| Form filed by One Reporting Person
|_| Form filed by More than One Reporting Person
================================================================================
- --------------------------------------------------------------------------------
Table I -- Non-Derivative Securities Beneficially Owned
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 5) (Instr. 5) (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Common Stock 2,079,409(1) D
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
* If the Form is filed by more than one Reporting Person see instruction
5(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
Page 1 of 3
<PAGE>
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------------------------------------
5. Owner-
3. Title and Amount of Securities ship
Underlying Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date --------------------------------- 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 7. Nature of
---------------------- or Exercise (D) or Indirect
Date Expira- Number Price of Indirect Beneficial
1. Title of Derivative Exer- tion of Derivative (I) Ownership
Security (Instr. 4) cisable Date Title Shares Security (Instr. 5) (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Warrant 1/25/2000 1/25/2005 Common 374,703 D
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
(1) See Attachment A
/s/ Lindsay A. Rosenwald February 8, 2000
- --------------------------------------------- -----------------------
**Lindsay A. Rosenwald, M.D. Date
Chariman of the General Partner
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, See Instruction 6 for procedure.
Page 2 of 3
<PAGE>
ATTACHMENT A
Reporting Person: The Aries Master Fund, a Cayman Islands
exempted company
Issuer: Urogen Corp.
Statement For: January 2000
Paramount Capital Asset Management, Inc. ("PCAM") is the general partner of each
of Aries I and Aries II and also serves as the investment manager of the Master
Fund. Dr. Rosenwald is the chairman and sole stockholder of PCAM. As a result,
Dr. Rosenwald and PCAM may be deemed to have voting and investment control over
the securities of the issuer owned by the Aries Funds under Rule 16a-(a)(1) of
the Securities Exchange Act of 1934. Dr. Rosenwald and PCAM disclaim beneficial
ownership of the securities held by the Aries Funds, except to the extent of its
pecuniary interest therein, if any.
Page 3 of 3
